Market Dynamics, Industry Moves and Technology Advancements
In 2022, the Orthobiologics Market encountered both ups and downs. Though companies are still reporting year-end results, SmartTRAK feels the Orthobiologics Market finished on a high note. The 2022 challenges, such as staffing shortages at healthcare facilities, supply chain constraints and inflation, may cause headwind in 2023, stifling some growth.
Nevertheless, SmartTRAK anticipates the potential downsides will be offset by elective procedures returning to pre-COVID levels, along with progressive, transitional initiatives by select market players that have the potential to reshape certain orthobiologics segment landscapes.
Among the many topics covered in this Market Outlook article are:
- Reshaping the Competitive Landscape
- Shifts in the US Bone Replacement Market
- Advancements in Osteobiologics
- Shifts in the US Sports Medicine Market